News Major shareholder announcement – BlackRock, Inc. Staff September 11, 2023 Iframe sync Post navigation Previous: Invivyd Announces Dosing of First Participant in CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of Symptomatic COVID-19 Next: Scinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in Boston More Stories Cancer Healthcare News AngioDynamics to Present at the 44th Annual J.P. Morgan Healthcare Conference Staff December 22, 2025 Healthcare News Nutrition Pharmaceutical Veterans World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares Staff December 22, 2025 Healthcare News Nutrition Pharmaceutical Balancing a Kidney Diet: Optimizing Nutrition Through Personalization Staff December 22, 2025
